Post-acute sequelae of SARS-CoV-2 (PASC), also known as Post-Covid Syndrome, and
colloquially as Long Covid, has been defined as a constellation of signs and symptoms …

Infectious diseases are commonly implicated as potential initiators of autoimmune diseases
(ADs) and represent the most commonly known factor in the development of autoimmunity in …

Background The immunopathological pathways enabling post-coronavirus disease 2019
(COVID-19) syndrome (PCS) development are not entirely known. We underwent a …

Background Autonomic dysfunction is a known complication of post-acute sequelae of
SARS-CoV-2 (PASC)/long COVID, however prevalence and severity are unknown …

Background As defined by the WHO, the term post-COVID syndrome (PCS) embraces a
group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and …

Several millions of individuals are estimated to develop post-acute sequelae SARS-CoV-2
condition (PASC) that persists for months after infection. Here we evaluate the immune …

Persistent breathlessness> 28 days after acute COVID-19 infection has been identified as a
highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms …

Abstract Consequences of Corona Virus Disease-19 (COVID-19) in patients with rheumatic
diseases (RDs) are clinically diverse. SARS-CoV-2 infection has been associated with …

What Do We Need to Know About Musculoskeletal Manifestations... : JBJS Reviews What Do
We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review …

ABSTRACT Introduction Post-COVID syndrome (PCS) is recognized as a new entity in the
context of SARS-CoV-2 infection. Though its pathogenesis is not completely understood …